|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.950 USD | +6.88% |
|
-4.22% | -19.40% |
| 15/05 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 21/04 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 9.8Cr 8.58Cr 7.92Cr 7.4Cr 14Cr 926.5Cr 14Cr 95Cr 37Cr 457.07Cr 37Cr 36Cr 1.59TCr | P/E 2026 * |
1.23x | P/E 2027 * | 5.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.8Cr 8.58Cr 7.92Cr 7.4Cr 14Cr 926.5Cr 14Cr 95Cr 37Cr 457.07Cr 37Cr 36Cr 1.59TCr | EV / Sales 2026 * |
1.23x | EV / Sales 2027 * | 0.73x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +6.88% | ||
| 1 week | -4.22% | ||
| Current month | +5.36% | ||
| 1 month | +5.36% | ||
| 3 months | +6.88% | ||
| 6 months | -17.60% | ||
| Current year | -19.40% |
| 1 week | 2.7 |  | 3.35 |
| 1 month | 2.53 | | 3.35 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.76 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 20/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 22/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 16/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 01/12/2008 |
| Chairman | 71 | 20/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 01/06/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/06 | Free | Chief Financial Officer | 4,00,000 | 1.2041% | ||
| 01/04 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 18/03 | Free | Chief Executive Officer | 4,75,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.88% | -4.22% | +62.09% | -65.50% | 9.8Cr | |
| -0.17% | +3.15% | +21.27% | -10.81% | 6.43TCr | |
| +0.80% | +5.52% | +59.09% | +227.09% | 5.73TCr | |
| +7.82% | +44.80% | +44.80% | +44.80% | 4.34TCr | |
| -0.56% | +2.41% | -52.09% | -58.63% | 3.8TCr | |
| +0.28% | +8.47% | +71.82% | -23.22% | 3.2TCr | |
| +3.61% | +17.45% | +156.63% | -42.92% | 2.77TCr | |
| +0.80% | +10.61% | +67.71% | +85.38% | 2.29TCr | |
| -0.56% | +4.05% | +1.53% | +168.92% | 1.77TCr | |
| -0.04% | -0.64% | +60.79% | +120.25% | 1.64TCr | |
| Average | +1.87% | +7.33% | +49.36% | +44.54% | 3.2TCr | |
| Weighted average by Cap. | +1.74% | +7.95% | +43.55% | +53.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.99Cr 6.99Cr 6.46Cr 6.03Cr 11Cr 755.18Cr 12Cr 78Cr 30Cr 372.56Cr 30Cr 29Cr 1.29TCr | 13Cr 12Cr 11Cr 10Cr 19Cr 1.27TCr 19Cr 130.49Cr 50Cr 625.7Cr 50Cr 49Cr 2.17TCr |
| Net income | 9.05Cr 7.93Cr 7.32Cr 6.83Cr 13Cr 855.74Cr 13Cr 88Cr 34Cr 422.17Cr 34Cr 33Cr 1.47TCr | 2.11Cr 1.85Cr 1.71Cr 1.6Cr 3Cr 199.78Cr 3.07Cr 21Cr 7.94Cr 99Cr 7.94Cr 7.76Cr 342.19Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $2.950 | +6.88% | 5,34,783 |
| 26/26/26 | $2.760 | -8.61% | 11,03,740 |
| 25/26/25 | $3.020 | -3.82% | 5,74,922 |
| 24/26/24 | $3.140 | -0.63% | 8,98,517 |
| 23/26/23 | $3.160 | +2.60% | 7,91,591 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
